The Effect of 17α-Hydroxyprogesterone Caproate on Preterm Birth in Women with an Ultrasound-Indicated Cerclage

We sought to determine if 17α-hydroxyprogesterone caproate (17P) reduces the rate of preterm birth (PTB) in women with an ultrasound-indicated cerclage (UIC). We retrospectively reviewed a cohort of women with a previous spontaneous PTB and current UIC placement for cervical length (CL) < 25 mm at < 23 (6)/ (7) weeks. The study group consisted of women treated with 17P; the control group consisted of women not treated with 17P. Primary outcome was spontaneous PTB < 35 weeks. Secondary outcomes included PTB < 32 weeks, PTB < 28 weeks, gestational age at delivery, and birth weight. A total of 58 women were identified; 15 (25.9%) received 17P, and 43 (74.1%) did not. 17P did not have a significant effect on PTB < 35 weeks (odds ratio 1.72, 95% confidence interval 0.50 to 5.89), nor did it have a significant effect on the secondary outcomes. Among women with a prior spontaneous PTB and current UIC for CL < 25 mm, 17P did not reduce the rate of PTB < 35 weeks.

[1]  J. Iams,et al.  The effect of treatment with 17 alpha-hydroxyprogesterone caproate on changes in cervical length over time. , 2009, American journal of obstetrics and gynecology.

[2]  A. Novetsky,et al.  A randomized trial of cerclage vs. 17 α-hydroxyprogesterone caproate for treatment of short cervix , 2009, Journal of perinatal medicine.

[3]  A. Vintzileos,et al.  Is midtrimester short cervix a sign of intraamniotic inflammation? , 2008, American journal of obstetrics and gynecology.

[4]  D. Wing,et al.  Multicenter randomized trial of cerclage for preterm birth prevention in high-risk women with shortened midtrimester cervical length. , 2008, American journal of obstetrics and gynecology.

[5]  F. Facchinetti1,et al.  17α-Hydroxy-Progesterone Effects on Cervical Proinflammatory Agents in Women at Risk for Preterm Delivery , 2008 .

[6]  A. Rebarber,et al.  The use of 17 alpha-hydroxyprogesterone caproate (17p) in women with cervical cerclage. , 2008, American journal of perinatology.

[7]  D. Corey,et al.  Progesterone receptor plays a major antiinflammatory role in human myometrial cells by antagonism of nuclear factor-kappaB activation of cyclooxygenase 2 expression. , 2006, Molecular endocrinology.

[8]  V. Berghella,et al.  Cerclage for Short Cervix on Ultrasonography: Meta-Analysis of Trials Using Individual Patient-Level Data , 2005, Obstetrics and gynecology.

[9]  R. P. Heine,et al.  Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. , 2003, The New England journal of medicine.

[10]  B. Sibai,et al.  Mid-trimester endovaginal sonography in women at high risk for spontaneous preterm birth. , 2001, JAMA.

[11]  Hans H. Zingg,et al.  Inhibition of oxytocin receptor function by direct binding of progesterone , 1998, Nature.

[12]  E. Norwitz.  Cervical length changes during preterm cervical ripening: effects of 17-α-hydroxyprogesterone caproate , 2008 .

[13]  ACOG Committee Opinion number 419 October 2008 (replaces no. 291, November 2003). Use of progesterone to reduce preterm birth. , 2008, Obstetrics and gynecology.